MindMatters | November 2020

MindMatters | November 2020

"I AM ONE IN 468"

ABTA Launches Public Awareness & Fundraising Campaign

Considered a rare disease, public awareness of brain tumors continues to remain low. And yet, with 1 in 468 people living with a brain tumor, it’s likely everyone knows someone impacted. 

A group of courageous brain tumor patients, survivors and caregivers, are sharing their stories through the “I AM ONE IN 468” campaign to help the public understand that while brain tumors are a rare disease, it’s actually Closer Than They Know.

We hope the campaign will elevate awareness of this unforgiving disease, and inspire the public and brain tumor community to make a donation to help the ABTA fund patient programs and research. 

As you meet Brandon, Billi, Yessenia, Sharon and Brian, you’ll see that many members of our community are battling this disease during the pandemic, serving as a reminder that brain tumors don’t stop for a pandemic.

Let’s unite to support them with critical patient services and breakthrough brain tumor research.

Mindmatters

Unraveling the Complexities of Brain Tumors

Cell by cell, experiment after experiment, these three researchers—past ABTA research grant recipients—are leading their careers in brain tumor research because of the potential impact for brain tumor patients and their families. 

Read More »
Mindmatters

We Built a Bigger Boat!

**Sponsored Content**

Larry loved his fiery, redheaded wife, Lynn. But when Lynn was diagnosed with glioblastoma (GBM), he knew things had to change. It was his turn to take care of his wife and build a bigger boat for them both. In recognition of Caregiver Awareness Month, he wants to share his story.

Read More »

Upcoming Events

NOVEMBER 14



Virtual Regional Meeting
Online, 8 AM CT

LEARN MORE

NOVEMBER 17



Navigating Your
Medical Care

Online, 1 PM CT

LEARN MORE

DECEMBER 9



COVID-19 & Brain Tumors
Online, 1 PM CT

LEARN MORE

DECEMBER 16



Know Your Tumor:
Acoustic Neuroma

Online, 1 PM CT

LEARN MORE


 

Sign up for our newsletter.

  • This field is for validation purposes and should be left unchanged.